Molecular mechanism of inhibitor bindings to bromodomain-containing protein 9 explored based on molecular dynamics simulations and calculations of binding free energies

References

• J.W. Tamkun, R. Deuring, M.P. Scott, M. Kissinger, A.M. Pattatucci, T.C. Kaufman, and J.A. Kennison, Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2SWI2, Cell 68 (1992), pp. 561–572. doi:10.1016/0092-8674(92)90191-E.
   PubMed Web of Science ®Google Scholar
• A. Speck-Planche and M.T. Scotti, BET bromodomain inhibitors: Fragment-based in silico design using multi-target QSAR models, Mol. Divers. 23 (2019), pp. 555–572.
   PubMed Web of Science ®Google Scholar
• L. Wang, Y. Wang, H. Sun, J. Zhao, and Q. Wang, Theoretical insight into molecular mechanisms of inhibitor bindings to bromodomain-containing protein 4 using molecular dynamics simulations and calculations of binding free energies, Chem. Phys. Lett. 736 (2019), pp. 136785.
   Web of Science ®Google Scholar
• A. Speck-Planche, Combining ensemble learning with a fragment-based topological approach to generate new molecular diversity in drug discovery: In silico design of Hsp90 inhibitors, ACS Omega 3 (2018), pp. 14704–14716. doi:10.1021/acsomega.8b02419.
   PubMed Web of Science ®Google Scholar
• J. Ferreira da Costa, D. Silva, O. Caamaño, J.M. Brea, M.I. Loza, C.R. Munteanu, A. Pazos, X. García-Mera, and H. González-Díaz, Perturbation theory/machine learning model of ChEMBL data for dopamine targets: Docking, synthesis, and assay of new l-prolyl-l-leucyl-glycinamide peptidomimetics, ACS Chem. Neurosci. 9 (2018), pp. 2572–2587. doi:10.1021/acschemneuro.8b00083.
   PubMed Web of Science ®Google Scholar
• F.J. Romero-Durán, N. Alonso, M. Yañez, O. Caamaño, X. García-Mera, and H. González-Díaz, Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives, Neuropharmacology 103 (2016), pp. 270–278. doi:10.1016/j.neuropharm.2015.12.019.
   PubMed Web of Science ®Google Scholar
• A. Speck-Planche and M.N.D.S. Cordeiro, Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins, Mol. Divers. 21 (2017), pp. 511–523. doi:10.1007/s11030-017-9731-1.
   PubMed Web of Science ®Google Scholar
• S.R. Haynes, C. Dollard, F. Winston, S. Beck, J. Trowsdale, and I.B. Dawid, The bromodomain: A conserved sequence found in human, Drosophila and yeast proteins, Nucleic Acids Res. 20 (1992), pp. 2603. doi:10.1093/nar/20.10.2603.
   PubMed Web of Science ®Google Scholar
• R. Tumdam, A. Kumar, N. Subbarao, and B.S. Balaji, In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1, SAR QSAR Environ. Res. 29 (2018), pp. 975–996.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos and S. Knapp, Targeting bromodomains: Epigenetic readers of lysine acetylation, Nat. Rev. Drug Discov. 13 (2014), pp. 337. doi:10.1038/nrd4286.
   PubMed Web of Science ®Google Scholar
• P. Filippakopoulos, S. Picaud, M. Mangos, T. Keates, J.-P. Lambert, D. Barsyte-Lovejoy, I. Felletar, R. Volkmer, S. Müller, T. Pawson, A.-C. Gingras, C.H. Arrowsmith, and S. Knapp, Histone recognition and large-scale structural analysis of the human bromodomain family, Cell 149 (2012), pp. 214–231. doi:10.1016/j.cell.2012.02.013.
   PubMed Web of Science ®Google Scholar
• X. Lucas, D. Wohlwend, M. Hügle, K. Schmidtkunz, S. Gerhardt, R. Schüle, M. Jung, O. Einsle, and S. Günther, 4-Acyl pyrroles: Mimicking acetylated lysines in histone code reading, Angew. Chem. Int. Edit. 52 (2013), pp. 14055–14059. doi:10.1002/anie.201307652.
   PubMed Web of Science ®Google Scholar
• B. Raux, Y. Voitovich, C. Derviaux, A. Lugari, E. Rebuffet, S. Milhas, S. Priet, T. Roux, E. Trinquet, J.-C. Guillemot, S. Knapp, J.-M. Brunel, A.Y. Fedorov, Y. Collette, P. Roche, S. Betzi, S. Combes, and X. Morelli, Exploring selective inhibition of the first bromodomain of the human bromodomain and extra-terminal domain (BET) proteins, J. Med. Chem. 59 (2016), pp. 1634–1641. doi:10.1021/acs.jmedchem.5b01708.
   PubMed Web of Science ®Google Scholar
• F. Winston and C.D. Allis, The bromodomain: A chromatin-targeting module? Nat. Struct. Biol. 6 (1999), pp. 601–604. doi:10.1038/10640.
   PubMedGoogle Scholar
• R. Jahagirdar, H. Zhang, S. Azhar, J. Tobin, S. Attwell, R. Yu, J. Wu, K.G. McLure, H.C. Hansen, G.S. Wagner, P.R. Young, R.A.K. Srivastava, N.C.W. Wong, and J. Johansson, A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice, Atherosclerosis 236 (2014), pp. 91–100. doi:10.1016/j.atherosclerosis.2014.06.008.
   PubMed Web of Science ®Google Scholar
• E. Middeljans, X. Wan, P.W. Jansen, V. Sharma, H.G. Stunnenberg, and C. Logie, SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes, Plos One 7 (2012), pp. e33834. doi:10.1371/journal.pone.0033834.
   PubMed Web of Science ®Google Scholar
• A.F. Hohmann and C.R. Vakoc, A rationale to target the SWI/SNF complex for cancer therapy, Trends Genet. 30 (2014), pp. 356–363. doi:10.1016/j.tig.2014.05.001.
   PubMed Web of Science ®Google Scholar
• D. Remillard, D.L. Buckley, J. Paulk, G.L. Brien, M. Sonnett, H.-S. Seo, S. Dastjerdi, M. Wühr, S. Dhe-Paganon, S.A. Armstrong, and J.E. Bradner, Degradation of the BAF complex factor BRD9 by heterobifunctional ligands, Angew. Chem. Int. Edit. 56 (2017), pp. 5738–5743. doi:10.1002/anie.201611281.
   PubMed Web of Science ®Google Scholar
• A.F. Hohmann, L.J. Martin, J.L. Minder, J.-S. Roe, J. Shi, S. Steurer, G. Bader, D. McConnell, M. Pearson, T. Gerstberger, T. Gottschamel, D. Thompson, Y. Suzuki, M. Koegl, and C.R. Vakoc, Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition, Nat. Chem. Biol. 12 (2016), pp. 672–679.
   PubMed Web of Science ®Google Scholar
• P.G.K. Clark, L.C.C. Vieira, C. Tallant, O. Fedorov, D.C. Singleton, C.M. Rogers, O.P. Monteiro, J.M. Bennett, R. Baronio, S. Müller, D.L. Daniels, J. Méndez, S. Knapp, P.E. Brennan, and D.J. Dixon, LP99: Discovery and synthesis of the first selective BRD7/9 bromodomain inhibitor, Angew. Chem. Int. Edit. 54 (2015), pp. 6217–6221. doi:10.1002/anie.201501394.
   PubMed Web of Science ®Google Scholar
• T.J. Ley, C. Miller, L. Ding, J. Baty, and L. Fulton, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New Engl. J. Med. 368 (2013), pp. 2059–2074.
   PubMed Web of Science ®Google Scholar
• L. Wang, Z. Zhao, M.B. Meyer, S. Saha, M. Yu, A. Guo, K.B. Wisinski, W. Huang, W. Cai, J.W. Pike, M. Yuan, P. Ahlquist, and W. Xu, CARM1 Methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis, Cancer Cell 25 (2014), pp. 21–36. doi:10.1016/j.ccr.2013.12.007.
   PubMed Web of Science ®Google Scholar
• S.P. Cleary, W.R. Jeck, X. Zhao, K. Chen, S.R. Selitsky, G.L. Savich, T.-X. Tan, M.C. Wu, G. Getz, M.S. Lawrence, J.S. Parker, J. Li, S. Powers, H. Kim, S. Fischer, M. Guindi, A. Ghanekar, and D.Y. Chiang, Identification of driver genes in hepatocellular carcinoma by exome sequencing, Hepatology 58 (2013), pp. 1693–1702. doi:10.1002/hep.26540.
   PubMed Web of Science ®Google Scholar
• C. Kadoch, D.C. Hargreaves, C. Hodges, L. Elias, L. Ho, J. Ranish, and G.R. Crabtree, Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy, Nat. Genet. 45 (2013), pp. 592–601.
   PubMed Web of Science ®Google Scholar
• A.F. Hohmann, L.J. Martin, J. Minder, J.-S. Roe, J. Shi, S. Steurer, G. Bader, D. McConnell, M. Pearson, T. Gerstberger, T. Gottschamel, D. Thompson, Y. Suzuki, M. Koegl, and C. Vakoc, Abstract LB-206: A bromodomain-swap allele demonstrates that on-target chemical inhibition of BRD9 limits the proliferation of acute myeloid leukemia cells, Cancer Res. 76 (2016), pp. LB–206.
   Web of Science ®Google Scholar
• J.U. Kang, S.H. Koo, K.C. Kwon, J.W. Park, and J.M. Kim, Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer, Cancer Genet. Cytogen. 182 (2008), pp. 1–11. doi:10.1016/j.cancergencyto.2007.12.004.
   PubMedGoogle Scholar
• L. Scotto, G. Narayan, S.V. Nandula, S. Subramaniyam, A.M. Kaufmann, J.D. Wright, B. Pothuri, M. Mansukhani, A. Schneider, H. Arias-Pulido, and V.V. Murty, Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha, Mol. Cancer 7 (2008), pp. 58.
   PubMed Web of Science ®Google Scholar
• D.A. Hay, C.M. Rogers, O. Fedorov, C. Tallant, S. Martin, O.P. Monteiro, S. Müller, S. Knapp, C.J. Schofield, and P.E. Brennan, Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains, Med. Chem. Commun. 6 (2015), pp. 1381–1386. doi:10.1039/C5MD00152H.
   Google Scholar
• C. Steilmann, M.C.O. Cavalcanti, M. Bartkuhn, J. Pons, H.-C. Schuppe, W. Weidner, K. Steger, and A. Paradowska-Dogan, The interaction of modified histones with the bromodomain testis-specific (BRDT) gene and its mRNA level in sperm of fertile donors and subfertile men, Reproduction (Cambridge, England) 140 (2010), pp. 435–443. doi:10.1530/REP-10-0139.
   PubMed Web of Science ®Google Scholar
• L. Guetzoyan, R.J. Ingham, N. Nikbin, J. Rossignol, M. Wolling, M. Baumert, N.A. Burgess-Brown, C.M. Strain-Damerell, L. Shrestha, P.E. Brennan, O. Fedorov, S. Knapp, and S.V. Ley, Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography, Med. Chem. Commun. 5 (2014), pp. 540–546. doi:10.1039/C4MD00007B.
   Google Scholar
• N.H. Theodoulou, P. Bamborough, A.J. Bannister, I. Becher, R.A. Bit, K.H. Che, C.-W. Chung, A. Dittmann, G. Drewes, D.H. Drewry, L. Gordon, P. Grandi, M. Leveridge, M. Lindon, A.-M. Michon, J. Molnar, S.C. Robson, N.C.O. Tomkinson, T. Kouzarides, R.K. Prinjha, and P.G. Humphreys, Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition, J. Med. Chem. 59 (2016), pp. 1425–1439. doi:10.1021/acs.jmedchem.5b00256.
   PubMed Web of Science ®Google Scholar
• T.D. Crawford, S. Vartanian, A. Côté, S. Bellon, M. Duplessis, E.M. Flynn, M. Hewitt, H.-R. Huang, J.R. Kiefer, J. Murray, C.G. Nasveschuk, E. Pardo, F.A. Romero, P. Sandy, Y. Tang, A.M. Taylor, V. Tsui, J. Wang, S. Wang, L. Zawadzke, B.K. Albrecht, S.R. Magnuson, A.G. Cochran, and D. Stokoe, Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance, Bioorg. Med. Chem. Lett. 27 (2017), pp. 3534–3541. doi:10.1016/j.bmcl.2017.05.063.
   PubMed Web of Science ®Google Scholar
• P. Zheng, J. Zhang, H. Ma, X. Yuan, P. Chen, J. Zhou, and H. Zhang, Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors, Bioorg. Med. Chem. 27 (2019), pp. 1391–1404. doi:10.1016/j.bmc.2019.02.045.
   PubMedGoogle Scholar
• H. Huang, Y. Wang, Q. Li, X. Fei, H. Ma, and R. Hu, miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9, Cancer Lett. 446 (2019), pp. 81–89. doi:10.1016/j.canlet.2019.01.007.
   PubMed Web of Science ®Google Scholar
• K.F. Krämer, N. Moreno, M.C. Frühwald, and K. Kerl, BRD9 Inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors, Int. J. Mol. Sci. 18 (2017), pp. 1537. doi:10.3390/ijms18071537.
   Web of Science ®Google Scholar
• P. Wang, T. Fu, X. Zhang, F. Yang, G. Zheng, W. Xue, Y. Chen, X. Yao, and F. Zhu, Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD, BBA-Gen. Subjects 1861 (2017), pp. 2766–2777. doi:10.1016/j.bbagen.2017.07.022.
   PubMed Web of Science ®Google Scholar
• G. Li, H. Shen, D. Zhang, Y. Li, and H. Wang, Coarse-grained modeling of nucleic acids using anisotropic gay–Berne and electric multipole potentials, J. Chem. Theory Comput. 12 (2016), pp. 676–693. doi:10.1021/acs.jctc.5b00903.
   PubMed Web of Science ®Google Scholar
• T. Hou, W.A. McLaughlin, and W. Wang, Evaluating the potency of HIV-1 protease drugs to combat resistance, Proteins 71 (2008), pp. 1163–1174. doi:10.1002/prot.21808.
   PubMed Web of Science ®Google Scholar
• M. Yang, X. Zhang, and K. Han, Molecular dynamics simulation of SRP GTPases: Towards an understanding of the complex formation from equilibrium fluctuations, Proteins 78 (2010), pp. 2222–2237. doi:10.1002/prot.v78:10.
   PubMed Web of Science ®Google Scholar
• H. Sun, Y. Li, M. Shen, D. Li, Y. Kang, and T. Hou, Characterizing drug–Target residence time with metadynamics: How to achieve dissociation rate efficiently without losing accuracy against time-consuming approaches, J. Chem. Inf. Model. 57 (2017), pp. 1895–1906. doi:10.1021/acs.jcim.7b00075.
   PubMed Web of Science ®Google Scholar
• E.L. Wu, K.-Y. Wong, X. Zhang, K. Han, and J. Gao, Determination of the structure form of the fourth ligand of zinc in acutolysin a using combined quantum mechanical and molecular mechanical simulation, J. Phys. Chem. B 113 (2009), pp. 2477–2485. doi:10.1021/jp808182y.
   PubMed Web of Science ®Google Scholar
• A. Bunker, P.T. Männistö, J.F.S. Pierre, T. Róg, P. Pomorski, L. Stimson, and M. Karttunen, Molecular dynamics simulations of the enzyme catechol-o-methyltransferase: Methodological issues, SAR QSAR Environ. Res. 19 (2008), pp. 179–189.
   PubMed Web of Science ®Google Scholar
• M.A. Azam, S. Jupudi, N. Saha, and R.K. Paul, Combining molecular docking and molecular dynamics studies for modelling Staphylococcus aureus MurD inhibitory activity, SAR QSAR Environ. Res. 30 (2019), pp. 1–20.
   PubMed Web of Science ®Google Scholar
• P.K. Singh and O. Silakari, Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC, SAR QSAR Environ. Res. 28 (2017), pp. 221–233.
   PubMed Web of Science ®Google Scholar
• M.-J. Yang, X.-Q. Pang, X. Zhang, and K.-L. Han, Molecular dynamics simulation reveals preorganization of the chloroplast FtsY towards complex formation induced by GTP binding, J. Struct. Biol. 173 (2011), pp. 57–66. doi:10.1016/j.jsb.2010.07.013.
   PubMed Web of Science ®Google Scholar
• Q. Shao, Z. Xu, J. Wang, J. Shi, and W. Zhu, Energetics and structural characterization of the “DFG-flip” conformational transition of B-RAF kinase: A SITS molecular dynamics study, Phys. Chem. Chem. Phys. 19 (2017), pp. 1257–1267. doi:10.1039/C6CP06624K.
   PubMed Web of Science ®Google Scholar
• W. Xue, F. Yang, P. Wang, G. Zheng, Y. Chen, X. Yao, and F. Zhu, What contributes to serotonin–norepinephrine reuptake inhibitors’ dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation, ACS Chem. Neurosci. 9 (2018), pp. 1128–1140.
   PubMed Web of Science ®Google Scholar
• T. Zhu, X. He, and J.Z.H. Zhang, Fragment density functional theory calculation of NMR chemical shifts for proteins with implicit solvation, Phys. Chem. Chem. Phys. 14 (2012), pp. 7837–7845. doi:10.1039/C2CP23746F.
   PubMed Web of Science ®Google Scholar
• J. Zhao, J. Chen, Y. Cui, J. Wang, L. Xia, Y. Dai, P. Song, and F. Ma, A questionable excited-state double-proton transfer mechanism for 3-hydroxyisoquinoline, Phys. Chem. Chem. Phys. 17 (2015), pp. 1142–1150. doi:10.1039/C4CP04135F.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, L. Pang, J.Z.H. Zhang, and T. Zhu, Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations, Nucleic Acids Res. 47 (2019), pp. 6618–6631. doi:10.1093/nar/gkz499.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, B. Yin, L. Pang, W. Wang, and W. Zhu, Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free-energy predictions, ACS Chem. Neurosci. 10 (2019), pp. 4303–4318.
   PubMed Web of Science ®Google Scholar
• T. Ichiye and M. Karplus, Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins 11 (1991), pp. 205–217. doi:10.1002/(ISSN)1097-0134.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, and W. Zhu, Zinc ion-induced conformational changes in new Delphi metallo-β-lactamase 1 probed by molecular dynamics simulations and umbrella sampling, Phys. Chem. Chem. Phys. 19 (2017), pp. 3067–3075. doi:10.1039/C6CP08105C.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, F. Lai, W. Wang, L. Pang, and W. Zhu, Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations, RSC Adv. 8 (2018), pp. 25456–25467. doi:10.1039/C8RA05042B.
   Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations, J. Biomol. Struct. Dyn. 36 (2018), pp. 1212–1224. doi:10.1080/07391102.2017.1317666.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, and W. Zhu, Mutation L1196M-induced conformational changes and the drug resistant mechanism of anaplastic lymphoma kinase studied by free energy perturbation and umbrella sampling, Phys. Chem. Chem. Phys. 19 (2017), pp. 30239–30248. doi:10.1039/C7CP05418A.
   PubMed Web of Science ®Google Scholar
• T. Hou, J. Wang, Y. Li, and W. Wang, Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking, J. Comput. Chem. 32 (2011), pp. 866–877. doi:10.1002/jcc.v32.5.
   PubMed Web of Science ®Google Scholar
• G. Hu, S. Xu, and J. Wang, Characterizing the free-energy landscape of MDM2 protein–Ligand interactions by steered molecular dynamics simulations, Chem. Biol. Drug Des. 86 (2015), pp. 1351–1359. doi:10.1111/cbdd.12598.
   PubMed Web of Science ®Google Scholar
• C. Suri and P.K. Naik, Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer, SAR QSAR Environ. Res. 26 (2015), pp. 507–519.
   PubMed Web of Science ®Google Scholar
• L. Duan, G. Feng, X. Wang, L. Wang, and Q. Zhang, Effect of electrostatic polarization and bridging water on CDK2–Ligand binding affinities calculated using a highly efficient interaction entropy method, Phys. Chem. Chem. Phys. 19 (2017), pp. 10140–10152. doi:10.1039/C7CP00841D.
   PubMed Web of Science ®Google Scholar
• W. Xue, P. Wang, G. Tu, F. Yang, G. Zheng, X. Li, X. Li, Y. Chen, X. Yao, and F. Zhu, Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder, Phys. Chem. Chem. Phys. 20 (2018), pp. 6606–6616. doi:10.1039/C7CP07869B.
   PubMed Web of Science ®Google Scholar
• Y. Gao, T. Zhu, and J. Chen, Exploring drug-resistant mechanisms of I84V mutation in HIV-1 protease toward different inhibitors by thermodynamics integration and solvated interaction energy method, Chem. Phys. Lett. 706 (2018), pp. 400–408.
   Web of Science ®Google Scholar
• L.L. Duan, G.Q. Feng, and Q.G. Zhang, Large-scale molecular dynamics simulation: Effect of polarization on thrombin-ligand binding energy, Sci. Rep. 6 (2016), pp. 31488.
   PubMedGoogle Scholar
• L. Duan, X. Liu, and J.Z.H. Zhang, Interaction entropy: A new paradigm for highly efficient and reliable computation of protein–Ligand binding free energy, J. Am. Chem. Soc. 138 (2016), pp. 5722–5728. doi:10.1021/jacs.6b02682.
   PubMed Web of Science ®Google Scholar
• S. Tian, J. Zeng, X. Liu, J. Chen, J.Z.H. Zhang, and T. Zhu, Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling, Chem. Chem. Phys. 21 (2019), pp. 22103–22112. doi:10.1039/C9CP03598B.
   PubMed Web of Science ®Google Scholar
• L.T. Song, J. Tu, R.R. Liu, M. Zhu, Y.J. Meng, and H.L. Zhai, Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations, J. Biomol. Struct. Dyn. 37 (2019), pp. 2970–2979. doi:10.1080/07391102.2018.1502097.
   PubMed Web of Science ®Google Scholar
• J. Zhao, H. Dong, and Y. Zheng, Theoretical insights into the excited state double proton transfer mechanism of deep red pigment alkannin, J. Phys. Chem. A 122 (2018), pp. 1200–1208. acs.jpca.7b10492.
   PubMed Web of Science ®Google Scholar
• J. Su, X. Liu, S. Zhang, F. Yan, Q. Zhang, and J. Chen, Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations, Chem. Biol. Drug Des. 93 (2019), pp. 163–176. doi:10.1111/cbdd.13398.
   PubMed Web of Science ®Google Scholar
• L.J. Martin, M. Koegl, G. Bader, X.-L. Cockcroft, O. Fedorov, D. Fiegen, T. Gerstberger, M.H. Hofmann, A.F. Hohmann, D. Kessler, S. Knapp, P. Knesl, S. Kornigg, S. Müller, H. Nar, C. Rogers, K. Rumpel, O. Schaaf, S. Steurer, C. Tallant, C.R. Vakoc, M. Zeeb, A. Zoephel, M. Pearson, G. Boehmelt, and D. McConnell, Structure-based design of an in vivo active selective BRD9 inhibitor, J. Med. Chem. 59 (2016), pp. 4462–4475. doi:10.1021/acs.jmedchem.5b01865.
   PubMed Web of Science ®Google Scholar
• D.A. Case, I.Y. Ben-Shalom, S.R. Brozell, D.S. Cerutti, I. Cheatham, T.E.V.W.D. Cruzeiro, T.A. Darden, R.E. Duke, D. Ghoreishi, M.K. Gilson, H. Gohlke, A.W. Goetz, D. Greene, R. Harris, N. Homeyer, Y. Huang, S. Izadi, A. Kovalenko, T. Kurtzman, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, D.J. Mermelstein, K.M. Merz, Y. Miao, G. Monard, C. Nguyen, H. Nguyen, I. Omelyan, A. Onufriev, F. Pan, R. Qi, D.R. Roe, A. Roitberg, C. Sagui, S. Schott-Verdugo, J. Shen, C.L. Simmerling, J. Smith, R. Salomon-Ferrer, J. Swails, R.C. Walker, J. Wang, H. Wei, R.M. Wolf, X. Wu, L. Xiao, D.M. York, and P.A. Kollman, Amber 2018, University of California, San Francisco, 2018.
   Google Scholar
• A. Jakalian, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem. 23 (2002), pp. 1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• D.C. Bas, D.M. Rogers, and J.H. Jensen, Very fast prediction and rationalization of pKa values for protein–Ligand complexes, Proteins 73 (2008), pp. 765–783. doi:10.1002/prot.22102.
   PubMed Web of Science ®Google Scholar
• H. Li, A.D. Robertson, and J.H. Jensen, Very fast empirical prediction and rationalization of protein pKa values, Proteins 61 (2005), pp. 704–721. doi:10.1002/prot.20660.
   PubMed Web of Science ®Google Scholar
• W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935.
   Web of Science ®Google Scholar
• A.W. Götz, M.J. Williamson, D. Xu, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born, J. Chem. Theory Comput. 8 (2012), pp. 1542–1555. doi:10.1021/ct200909j.
   PubMed Web of Science ®Google Scholar
• R. Salomon-Ferrer, A.W. Götz, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald, J. Chem. Theory Comput. 9 (2013), pp. 3878–3888. doi:10.1021/ct400314y.
   PubMed Web of Science ®Google Scholar
• J.-P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes, J. Comput. Phys. 23 (1977), pp. 327–341. doi:10.1016/0021-9991(77)90098-5.
   Web of Science ®Google Scholar
• T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092.
   Web of Science ®Google Scholar
• U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995), pp. 8577–8593.
   Web of Science ®Google Scholar
• D.M. York, T.A. Darden, and L.G. Pedersen, The effect of long‐range electrostatic interactions in simulations of macromolecular crystals: A comparison of the Ewald and truncated list methods, J. Chem. Phys. 99 (1993), pp. 8345–8348.
   Web of Science ®Google Scholar
• R.M. Levy, A.R. Srinivasan, W.K. Olson, and J.A. McCammon, Quasi-harmonic method for studying very low frequency modes in proteins, Biopolymers 23 (1984), pp. 1099–1112. doi:10.1002/(ISSN)1097-0282.
   PubMed Web of Science ®Google Scholar
• A.E. García, Large-amplitude nonlinear motions in proteins, Phys. Rev. Lett. 68 (1992), pp. 2696–2699. doi:10.1103/PhysRevLett.68.2696.
   PubMed Web of Science ®Google Scholar
• J. Chen, B. Yin, L. Pang, W. Wang, J.Z.H. Zhang, and T. Zhu, Binding modes and conformational changes of FK506-binding protein 51 induced by inhibitor bindings: Insight into molecular mechanisms based on multiple simulation technologies, J. Biomol. Struct. Dyn. (2019), pp. 1–15. doi:10.1080/07391102.2019.1624616
   Web of Science ®Google Scholar
• J. Chen, X. Wang, T. Zhu, Q. Zhang, and J.Z.H. Zhang, A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 Protease based on thermodynamic integration and MM-PBSA methods, J. Chem. Inf. Model. 55 (2015), pp. 1903–1913. doi:10.1021/acs.jcim.5b00173.
   PubMed Web of Science ®Google Scholar
• D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:10.1021/ct400341p.
   PubMed Web of Science ®Google Scholar
• M.A. Azam and J. Thathan, Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors, SAR QSAR Environ. Res. 28 (2017), pp. 275–296.
   PubMed Web of Science ®Google Scholar
• J. Wang, Q. Shao, B.P. Cossins, J. Shi, K. Chen, and W. Zhu, Thermodynamics calculation of protein–Ligand interactions by QM/MM polarizable charge parameters, J. Biomol. Struct. Dyn. 34 (2016), pp. 163–176. doi:10.1080/07391102.2015.1019928.
   PubMed Web of Science ®Google Scholar
• T. Hou, N. Li, Y. Li, and W. Wang, Characterization of domain-peptide interaction interface: Prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models, J. Proteome Res. 11 (2012), pp. 2982–2995. doi:10.1021/pr3000688.
   PubMed Web of Science ®Google Scholar
• A. Onufriev, D. Bashford, and D.A. Case, Exploring protein native states and large-scale conformational changes with a modified generalized born model, Proteins 55 (2004), pp. 383–394. doi:10.1002/prot.20033.
   PubMed Web of Science ®Google Scholar
• H. Gohlke, C. Kiel, and D.A. Case, Insights into protein–Protein binding by binding free energy calculation and free energy decomposition for the Ras–Raf and Ras–RalGDS complexes, J. Mol. Biol. 330 (2003), pp. 891–913. doi:10.1016/S0022-2836(03)00610-7.
   PubMed Web of Science ®Google Scholar
• X. Jiang, G. Chen, and L. Wang, Structural and dynamic evolution of the amphipathic n-terminus diversify enzyme thermostability in the glycoside hydrolase family 12, Phys. Chem. Chem. Phys. 18 (2016), pp. 21340–21350. doi:10.1039/C6CP02998A.
   PubMed Web of Science ®Google Scholar